Invacare 2012 Annual Report Download - page 122
Download and view the complete annual report
Please find page 122 of the 2012 Invacare annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.INVACARE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Foreign exchange forward contracts not qualifying or designated for hedge accounting treatment entered
into in 2012 and 2011, respectively, and outstanding were as follows (in thousands USD):
December 31, 2012 December 31, 2011
Notional
Amount
Gain
(Loss)
Notional
Amount
Gain
(Loss)
CAD/USD.............................. $ 22,194 $ (90) $ 2,146 $ 12
EUR/USD .............................. 18,060 416 — —
CHF/USD .............................. 2,144 42 3,419 (118)
GBP/USD .............................. 3,514 60 — —
CAD/AUD ............................. 1,508 3 — —
EUR/AUD ............................. 1,928 51 — —
GBP/AUD.............................. 1,356 26 — —
NOK/AUD ............................. 1,039 40 — —
NZD/AUD ............................. 2,128 25 — —
SEK/CAD .............................. — — 2,545 52
EUR/CAD.............................. — — 4,244 (10)
EUR/DKK ............................. 11,555 (28) 3,482 —
$ 65,426 $ 545 $ 15,836 $ (64)
The fair values of the company’s derivative instruments were as follows (in thousands):
December 31, 2012 December 31, 2011
Assets Liabilities Assets Liabilities
Derivatives designated as hedging instruments
under ASC 815
Foreign currency forward contracts ......... $ 375 $ 915 $ 1,621 $ 377
Interest rate swap contracts ............... — 316 18 388
Derivatives not designated as hedging
instruments under ASC 815
Foreign currency forward contracts ......... 687 142 64 128
Total derivatives ......................... $ 1,062 $ 1,373 $ 1,703 $ 893
The fair values of the company’s foreign currency forward assets and liabilities are included in Other
Current Assets and Accrued Expenses, respectively in the Consolidated Balance Sheets.
FS-42